Investing Ideas
/
Swiss Pharmaceuticals & Biotech Top Stock Picks from Analysts

Swiss Pharmaceuticals & Biotech Top Stock Picks from Analysts

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies which are more than 50% undervalued based on analyst price target.

7 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
DESN Dottikon ES Holding	CHF 214.00	-0.2%	-9.7%	CHF 3.0b	CHF 350.00	PE39.2x	S16.4%	0%
PPGN PolyPeptide Group	CHF 23.05	4.8%	40.3%	CHF 753.7m	CHF 36.16	PS2.5x	E64.9%	0%
BSLN Basilea Pharmaceutica	CHF 44.10	10.1%	21.5%	CHF 536.4m	CHF 76.92	PE6.9x	E6.5%	0%
SANN Santhera Pharmaceuticals Holding	CHF 16.46	4.8%	61.7%	CHF 209.1m	CHF 25.00	PE3.3x	S-76.7%	n/a
MOLN Molecular Partners	CHF 4.52	3.2%	14.3%	CHF 165.9m	CHF 9.75	PS27.7x	E-9.2%	n/a
CURN Curatis Holding	CHF 11.40	-5.0%	n/a	CHF 54.6m	CHF 20.00	n/a	n/a	n/a
ADXN Addex Therapeutics	CHF 0.06	9.1%	-14.5%	CHF 5.9m	CHF 0.16	PS10x	E18.5%	n/a

Page 1 of 1